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The extended amygdala, composed by the amygdaloid nuclei and the bed nucleus of
the stria terminalis (BNST), plays a critical role in anxiety behavior. In particular, the link
between the central nucleus of the amygdala (CeA) and the BNST seems to be critical
to the formation of anxiety-like behavior. Chronic unpredictable stress (CUS) exposure
is recognized as a validated animal model of anxiety and is known to trigger significant
morphofunctional changes in the extended amygdala. Quite surprisingly, no study has
ever analyzed the role of the CeA in the onset of stress-induced anxiety and fear
conditioning behaviors; thus, in the present study we induced a bilateral excitotoxic lesion
in the CeA of rats that were subsequently exposed to a chronic stress protocol. Data
shows that the lesion in the CeA induces different results in anxiety and fear-behaviors.
More specifically, lesioned animals display attenuation of the stress response and of
stress-induced anxiety-like behavior measured in the elevated-plus maze (EPM) when
compared with stressed animals with sham lesions. This attenuation was paralleled by
a decrease of stress-induced corticosterone levels. In contrast, we did not observe any
significant effect of the lesion in the acoustic startle paradigm. As expected, lesion of the
CeA precluded the appearance of fear behavior in a fear-potentiated startle paradigm in
both non-stressed and stressed rats. These results confirm the implication of the CeA in
fear conditioning behavior and unravel the relevance of this brain region in the regulation
of the HPA axis activity and in the onset of anxiety behavior triggered by stress.
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INTRODUCTION
Anxiety disorders are very prevalent (Kessler et al., 2009). Anxiety
is characterized by a sensation of discomfort and apprehension in
response to unconditioned diffuse cues (Koch, 1999). It is well-
established that exposure to chronic stress is a triggering factor
for development of anxiety. Stress induces several alterations in
the central nervous system, with particular relevance to areas in
the limbic system that regulate the stress response and emotional
behavior. It has been shown that different models of stress can
alter dendritic and synaptic plasticity with contrasting patterns,
namely atrophy in the prefrontal cortex (Cerqueira et al., 2005,
2007; Dias-Ferreira et al., 2009) and hippocampus (Bessa et al.,
2009) and hypertrophy in the bed nucleus of the stria terminalis
(BNST; Pêgo et al., 2008) and the amygdala (Vyas et al., 2002,
2003; McEwen et al., 2012).
Among the limbic structures, the extended amygdala, which
comprises, among other areas, the BNST and the central nucleus
of the amygdala (CeA) (Alheid et al., 1998) plays a major role
in the modulation of anxiety behavior. In particular, CeA is an
Abbreviations: BNST, Bed Nucleus of the Stria Terminalis; CeA, Central Nucleus
of the Amygdala; Cont, Control; CRF, Corticotrophin Releasing Factor; CUS,
Chronic Unpredictable Stress; EPM, Elevated-Plus Maze; HPA, Hypothalamus-
Pituitary-Adrenals; PBS, Phosphate buffer solution; PVN, Paraventricular Nucleus
of the Hypothalamus; SEM, Standard Error of the Mean.
output area of the amygdala and is involved in both fear and anxi-
ety behaviors (Walker et al., 2009; Davis et al., 2010). Although the
CeA does not have strong direct projections to the hypothalamus
(Moga and Saper, 1994; Prewitt and Herman, 1998), its activation
will lead to the stimulation of hypothalamic nuclei and areas that
are responsible for fear and stress responses (Beaulieu et al., 1987;
Shepard et al., 2006). This stimulation occurs largely through a
massive projection from CeA to the BNST, a region that in turn
projects densely to the paraventricular nucleus of the hypothala-
mus (PVN) (Dong et al., 2001). Indeed, it is presently recognized
that the BNST acts as a relay station between upper limbic areas
and the PVN, playing a fundamental role in the modulation of the
stress response and anxiety behaviors (Herman et al., 2005; Choi
et al., 2007).
The connection between the CeA and the BNST occurs
through the stria terminalis, a bundle of projection fibers that
include GABAergic neurons co-expressing peptides such as cor-
ticotrophin releasing factor (CRF) or enkephalin (Veinante et al.,
1997; Day et al., 1999). Of relevance, CRF is highly expressed in
the CeA, with this region being one major extra-hypothalamic
source of this peptide. Due to the role of CRF in stress response,
it has been proposed that neurons expressing CRF in the CeA are
involved in stress related anxiety and fear behavior (Davis, 1992;
Makino et al., 1995). It was shown that exposure to stress induces
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increased expression of CRF in several brain regions, including
the extended amygdala (Kalin et al., 1994; Makino et al., 1994;
Cook, 2004; Shepard et al., 2006). Previous reports have shown
that a lesion in CeA is able to alter the basal levels of CRF in
the PVN but interestingly not after stress (Prewitt and Herman,
1997). Quite surprisingly, to the best of our knowledge, there
are no reports about the consequences of lesions in the CeA in
the development of anxiety-like behavior in a rodent model of
chronic stress. To further understand the role that this area plays
in anxiety and the fear-potentiated startle behavior we assessed
how excitotoxic lesions of CeA affect the development of anxiety
induced by a chronic unpredictable stress (CUS) paradigm.
MATERIALS AND METHODS
ANIMALS AND TREATMENTS
Animal experiments were conducted in accordance with the
European Communities Council Directive (86/609/EEC) and the
NIH guidelines on animal care and experimentation. All exper-
iments were approved by the Animal Ethics Committee of the
Portuguese National Veterinary Directorate.
Adult male Wistar rats (Charles Rivers Laboratories,
Barcelona, Spain) were housed in groups of 2 per cage under
standard laboratory conditions (temperature 22◦C; artificial
light/dark cycle of 12/12 h; lights on at 8 a.m) and with ad-libitum
access to commercial chow and water.
SURGERY
Forty male rats (8 weeks old) were submitted to stereotaxic
surgery under ketamine/medetomidine anaesthesia. The animals
were randomly distributed to one of two groups. A group of ani-
mals was injected with phosphate buffer solution (PBS) (n = 20)
and other (n = 20) with ibotenic acid (Sigma-Aldrich, St. Louis,
Misouri, USA) in the central amygdala (−2.2mm from bregma,
4.2mm from midline, 7.0mm from brain surface). Ibotenic acid
(10mg/ml) was injected at a rate of 0.05µl/min for a total volume
of 0.2µl.
After the surgery animals were given 1 week to rest and then
were subdivided into four groups: Control-Sham (Cont-Sham;
n = 10 randomly chosen from animals injected with vehicle);
control-lesion (Cont-Lesion; n = 10 randomly chosen from ani-
mals that received ibotenic acid); a CUS-Sham (n = 10 cor-
responding to animals injected with vehicle) and CUS-Lesion
(n = 10 from the animals injected with ibotenic acid).
STRESS PROTOCOL
Stress protocol started when the animals were 9 weeks of age,
and it lasted 28 days. Animals were exposed to one different
stressor per day (30min/day) of one of the following aversive
stimuli: immersion in cold water (18◦C), vibration of the home
cage, restraining, overcrowding, and exposure to a hot air stream
(Cerqueira et al., 2007). The stressors were scheduled in a random
order for the duration of the experiment. Control animals were
handled on a daily basis over the 4 weeks. Weekly body weights
and post-mortem weight of adrenals and thymus were recorded
as indicator of the efficacy of the stress protocol (Table 1).
BEHAVIORAL TESTS
After the end of the stress exposure a behavioral evaluation was
performed to assess anxiety-like behavior [elevated-plus maze
(EPM) and acoustic startle], fear conditioning (fear-potentiated
startle) and locomotor activity (open field). Behavioral tests were
performed in the following order to minimize the effects each test
could have in the following test: EPM, open field, acoustic star-
tle and fear-potentiated startle. The behavioral tests started 24 h
after the last stressor was applied. The acoustic startle and fear-
potentiated startle were spaced 1 week in which the animals were
still submitted to the chronic stress protocol.
ELEVATED PLUS MAZE
Animals were tested over 5min in a black polypropylene “plus”-
shaped maze (ENV-560, MedAssociates Inc, St. Albans, VT
05478) at a height of 72 cm above the floor (EPM). The maze
consisted of two facing open arms (50.8 × 10.2 cm) and two
closed arms (50.8 × 10.2 × 40.6 cm). Testing was performed
under bright white light. The time spent in the open arms, junc-
tion area and closed arms, as well as the number of entrances
and explorations in each section were recorded using a system of
infrared photobeams, the crossings of which were monitored by
computer. The times spent in each of the compartments of the
EPM are presented as percentage of the total duration of the trial.
ACOUSTIC STARTLE
Startle reflex (ASR) was measured in startle response apparatuses
(SR-LAB, San Diego Instruments, San Diego, CA, USA), each
consisting of a non-restrictive Plexiglas cylinder (inner diame-
ter 8.8 cm, length 22.2 cm), mounted on a Plexiglas platform and
placed in a ventilated, sound-attenuated chamber. Animals were
habituated to the apparatus (5min daily) for 2 days before actual
testing. Cylinder movements were detected and measured by a
piezoelectric element mounted under each cylinder. A dynamic
calibration system (San Diego Instruments, San Diego, CA, USA)
was used to ensure comparable startle magnitudes. Startle stim-
uli were presented through a high frequency speaker located
33 cm above the startle chambers. Animals were presented with
Table 1 | Biometric markers revealed that the CUS protocol decreased body-weight gain.
Control-sham Control-lesion CUS-sham CUS-lesion Significance
Body weight gain (g) 98.2 ± 2.5 106.2 ± 2.4 83.8 ± 3.6 90.3 ± 2.9 F(1, 37) = 3.48 P < 0.05
Thymus weight (gr/BW) 0.46 ± 0.02 0.47 ± 0.01 0.37 ± 0.01 0.38 ± 0.01 F(1, 37) = 4.45 P < 0.110
Adrenal weight (gr/BW) 0.44 ± 0.01 0.46 ± 0.01 0.52 ± 0.01 0.48 ± 0.01 F(1, 37) = 1.35 P < 0.32
Significance corresponds to the ANOVA between groups. Data presented as Mean ± SEM.
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60 startle stimuli each lasting 50ms but with different intensities,
from 70 to 120 db applied in a random order. The startle stim-
uli were presented with a random duration between each startle:
from 5 to 20 s. Startle magnitudes were sampled every millisec-
ond (ms) over a period of 200ms, beginning with the onset of the
startle stimulus. A startle response is defined as the peak response
during 200ms recording period.
FEAR-POTENTIATED STARTLE
Rats were placed in the first test chamber, a non-restrictive
Plexiglas cylinder (inner diameter 8.8 cm, length 22.2 cm), the
floor of which consisted of a stainless steel grid through which
a software-controlled electric current could be passed. Animals
were rehabituated to the startle chamber for 5min and 5 baseline
trials were administered (50-ms pulse of white noise at 120 dB)
at an interstimulus interval of 30 s. The purpose of these base-
line trials was to familiarize the animal with the startle stimulus
in order to facilitate more accurate measurement of the animal’s
overall startle amplitude. Next, animals were presented with 20
light-shock pairings, at 30 s intervals. The shock (0.6mA) was
presented during the last 500ms of the 5 s light pulse. The light
stimulus was delivered via a 3-watt incandescent light bulb fas-
tened to the inside wall of the startle chamber. After completion
of the conditioning trials, animals were returned to their home
cages. The same testing procedure was applied on the following
day, except that 20, rather than 5, baseline trials were administered
before testing. Additionally, startle measurements were made in
the same grid holder that was used to condition the animals.
After delivery of the final baseline trial, animals were randomly
presented 10 startle stimuli, each with an intensity of 120 dB
and duration of 50ms. In half of the trials, the startle stimulus
was presented concomitantly with the conditioned stimulus (CS
light). Startle stimuli paired with the CS were delivered during
the last 50ms of the 5 s light presentation. The magnitude of the
difference between the startle response at 120 db (Vmax) in the
presence or absence of the CS will be a reflection of fear-behavior.
(Walker et al., 2003).
OPEN FIELD
Animals were individually tested for 5min each in an open field
(OF) arena (43.2 × 43.2 cm) that had transparent acrylic walls
and awhite floor (model ENV-515,MedAssociates Inc, St. Albans,
VT 05478). Each subject was initially placed in the center of the
arena and horizontal activity and instant position were regis-
tered, using a system of two 16-beam infrared arrays connected
to a computer. Total distances were used as indicators of locomo-
tor activity. Times and distances in the pre-defined central and
peripheral areas were recorded and used to calculate the ratio
of time spent in the central area over total time of the trial,
and distance travelled in the central as a function of total area.
Number and duration of rearings were recorded. The test room
was illuminated with bright white light.
Corticosterone measurement
At the end of the stress protocol (24 h after the last stressor)
blood was collected for corticosterone assessment. Collection was
performed at different time-points: one between 9 and 10 a.m.
(starting 1 h after “lights on”) and the other between 6 and 7 p.m.
(ending 1 h before “lights off”). The blood was rapidly collected
after a small incision in the tail of the animals. After collection,
blood was centrifuged at 13,000 rpm for 10min. Serum (super-
natant) was removed and stored at −80◦C until further analy-
sis. Corticosterone levels were measured by radioimmunoassay
using a commercial kit (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s instructions. Briefly, serum sam-
ples were diluted (1:200) with steroid diluent. After dilution,
100µL of each serum sample were added to the respective tube
in duplicate. To each sample, 200µL of Corticosterone 125-I
was added, immediately followed by addition of 200µL of anti-
CORT. Samples were incubated at room temperature for 2 h.
After incubation, 500µL of precipitant solution was added to
all samples and then centrifuged at 2500 rpm for 15min. CORT
concentration in the precipitate was measured using an auto-
matic gamma counter (Perkin Elmer 1470, Manchester, United
Kingdom).
HISTOLOGICAL PROCEDURES
Following behavioral tests the animals were deeply anaesthetized
with pentobarbital and perfused transcardiacally with saline.
Brains were collected, involved in Optimal Cutting-Temperature
compound (Leica Biosystems, Wetzlar, Germany) and frozen. The
brains were kept at −20◦C until histological processed; 20µm
coronal sections were obtained in a cryostat (Leica) and stained
with cresyl violet to assess the location of lesions (Figure 1).
FIGURE 1 | Representative picture of the lesion sites in the Central Nucleus of the Amygdala (CeA). Atlas section according to Swanson (1998).
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STATISTICAL ANALYSIS
Results are expressed as mean ± standard error of the mean
(SEM). Statistical analysis was performed using repeated mea-
sures test or Two-WayANOVA to comparemeans between groups
where appropriate. Post-hoc analysis was performed using LSD
test. Statistical significance was accepted when p < 0.05.
RESULTS
The stress treatment induced an overall alteration in body weight
gain [F(1, 37) = 16.31; p < 0.001; Table 1]. Exposure to CUS pro-
tocol lead to a significant decrease in body-weight gain when
compared with control groups (p < 0.05; Table 1) although ani-
mals with lesion in central amygdala (CUS-Lesion) had a smaller
reduction in body-weight gain when compared with CUS-Sham
(Table 1). Both CUS groups showed a non-significant decrease in
thymus weight when compared with control animals (Table 1).
CUS-Sham animals showed a non-significant increase in adrenal
weight when compared with both control groups and CUS-
Lesion animals (Table 1). The efficacy of the stress was also
measured by assessing the corticosterone levels in the blood. The
treatment induced an overall alteration of the plasma corticos-
terone levels 1 h after “lights on” (from 9 to 10 a.m.) [Interaction:
F(1, 30) = 6.70; p = 0.015] with stressed animals showing an
increase in corticosterone when comparing with controls (Cont-
Sham vs. CUS-Sham: p < 0.001; Cont-Sham vs. CUS-Lesion: p =
0.01; Cont-Lesion vs. CUS-Sham: p < 0.001). The presence of a
lesion in the CeA was able to attenuate the increase of the lev-
els of corticosterone in the plasma induced by stress (CUS-Sham
vs. CUS-Lesion: p = 0.015) (Figure 2). There were no differences
between the plasma corticosterone levels measured from 6 to
7 p.m. (data not shown).
In the EPM, we observe differences between groups in the
time spent in open arms [interaction: F(1, 42) = 4.26; p = 0.044].
CUS induced anxiety-like behavior in non-lesioned animals when
comparing with controls as revealed by the reduction of time
spent in open arms [F(1, 42) = 19.47; p < 0.01] and by the
reduced number of entries in the open arm [F(1, 42) = 7.89; p <
0.001]. In contrast, in CeA lesioned animals, the same CUS pro-
tocol did not induce a significant decrease in the time spent
in the open arms (Cont-Lesion vs. CUS-Lesion: p = 0.164);
FIGURE 2 | Corticosterone levels measured in the plasma of rats
collected from 9 to 10 a.m. CUS induces an increase in corticosterone
levels when comparing with controls. Interestingly, stressed animals
lesioned in the CeA display an attenuation of this increase in corticosterone
levels. CUS, chronic unpredictable stress; ∗p < 0.05; ∗∗∗p < 0.001. Results
are presented as Mean + SEM.
importantly, the comparison amongst CUS groups show a
decreased anxiety-like behavior with stressed-lesioned animals
spending more time in open arms than stressed non-lesioned
animals (CUS-Sham vs. CUS-Lesion p < 0.048). The compari-
son amongst control groups did not reveal an effect of the CeA
lesion in this parameter (p = 0.44), which demonstrates that the
lesion on its own is not able to induce behavioral alterations in the
EPM. Furthermore, there was no significant difference between
groups in the number of explorations or the number of entrances
in closed arms, showing that the animals presented similar
exploratory/locomotor activity [Interaction between treatments:
Entrances: F(1, 40) = 0.513, p = 0.68; Explorations: F(1, 40) =
0.427, p = 0.74] (Figure 3).
Locomotor activity was assessed with the open field test and
no differences were found for the interaction between treat-
ments or between control groups and animals submitted to CUS
protocol [F(1, 42) = 1.07, p = 0.37]. Furthermore, there were no
significant differences between groups in the time spent in cen-
ter/peripheral areas of the open-field [F(1, 42) = 0.18, p = 0.68]
or in the number of rearings and in the time spent in rearing activ-
ity, indicating no alterations in exploratory activity [F(1, 42) =
1.87, p = 0.46] (Figure 4).
In the acoustic startle test there is an overall increase in
responsiveness to the stimuli with the experimental procedures
[F(1, 32) = 3.99, p = 0.02]. Despite a trend for an attenuation in
the responsiveness to the startle in stressed animals injected with
ibotenic acid (CUS-Lesion) when compared with CUS-Sham
group, this difference did not reach statistical significance (at 120
db: p = 0.16). There was also no significant difference between
both control groups (Figure 5). These results suggest that a lesion
in the CeA may attenuate the stress effects in this reflex response.
We have also evaluated the fear-potentiated startle of these ani-
mals and found that the interaction between stress and lesion does
not induce any significant differences [F(1, 21) = 2.74; p = 0.12].
Nevertheless, animals lesioned in the CeA displayed significant
alterations in startle behavior [F(1, 21) = 9.64; p = 0.061] when
compared with non-lesioned animals. (Figure 6).
DISCUSSION
Herein, we show for the first time that excitotoxic lesions in the
CeA attenuate stress-induced anxiety behavior and also atten-
uated the activation of the HPA axis. Previous studies have
demonstrated that lesions in CeA affect the manifestation of
fear-behavior but not light-enhanced startle, a behavior more
associated with a display of anxiety (Walker and Davis, 2008;
Davis et al., 2010). In fact, it is widely accepted that while amyg-
dala is essential for the manifestation of fear-behavior, the BNST
is more determinant for anxiety-like behavior (Walker et al., 2003;
Hammack et al., 2004; Lee et al., 2008). It is important to note
that the attenuation of the stress-induced anxiety in the CeA
lesioned animals was observed under stress conditions but it did
not induce any alteration in anxiety-like behavior in control ani-
mals. In other words, it demonstrates that the integrity of the
CeA is required for the establishment of stress-induced hyper-
anxiety but does not mediate anxiety behavior per se. Similarly,
CeA lesions were able to blunt the increase in circulating cor-
ticosteroids induced by stress exposure while not altering the
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FIGURE 3 | Anxiety-like behavior measured in the Elevated Plus-Maze. (A) Percentage of time spent in open arms. (B) Mean number of entrances in the
open and closed arms. CUS, chronic unpredictable stress; ∗p < 0.05; ∗∗p < 0.01. Results are presented as Mean + SEM.
FIGURE 4 | Open field test. (A) Total distance ran in the open field test. (B) Ratio between time spent in center and periphery. No statistical differences were
found between groups. CUS, chronic unpredictable stress. Results are presented as Mean + SEM.
FIGURE 5 | Acoustic startle responses. Startle amplitude in response to
an acoustic stimulus. CUS induces an increase in the startle when
comparing with controls. CUS, chronic unpredictable stress; ∗p < 0.05.
Results are presented as mean ± SEM.
FIGURE 6 | Fear-potentiated startle responses. Startle amplitude in
response to an acoustic stimulus. No statistical differences were found
between groups. CS, conditioned stimulus; CUS, chronic unpredictable
stress rats. Vmax—startle amplitude at 120 db. Results are presented as
mean ± SEM. ∗p < 0.05.
levels of corticosteroids in control animals. In accordance, previ-
ous reports have shown (Prewitt and Herman, 1997) that animals
that were lesioned in CeA show impaired activation of the HPA
axis after stress, as well as no alterations in adrenals and thymus
weight when compared with controls.
It is important to highlight that the attenuation of stress-
induced anxiety is not complete, which suggests that other path-
ways are still conveying the changes in the neuronal networks
that rule stress-induced anxiety behavior. This is not surpris-
ing if one considers that there are several factors contributing
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to the activity of anxiety circuits, namely at BNST level. Of
relevance, the anterior BNST receives a strong glutamatergic pro-
jection from the infralimbic cortex that will likely contribute to
anxiety-like behavior (Sesack et al., 1989; Hurley et al., 1991;
Massi et al., 2008). Surprisingly, differences in anxiety behavior
were not coincident among behavioral tests. While CeA lesions
attenuated anxiety-like behavior in the EPMwe only found a non-
significant trend in the acoustic startle response. Additionally,
no differences were found in the open field test between con-
trol and CUS animals or any effect of lesions. In fact, these
results were already described by our group (Pêgo et al., 2008).
This apparent discrepancy may reflect specificity of the effect
of treatment and/or lesion on these behavioral tasks. While all
behavioral tasks are affected by the baseline level of anxiety of
the individual, the EPM additionally reflects a decision-making
process that involves cortical processing and assessment. Cortical
functions are known to be affected by CUS (Cerqueira et al.,
2007) and the specificity of the observed changes in the EPM
may reflect this particular sensitivity of upstream regulatory areas
like the prefontal cortex to stress. Reflex behavior, which is not
mediated by the amygdala (Koch and Schnitzler, 1997) or pure
exploratory behavior as observed in the open field is unlikely to
be affected by cortical functions and this may justify the results
reported.
In contrast, we confirmed that a fully functional CeA is
essential for the manifestation of fear behavior, measured in
the fear-potentiated startle. In fact, a lesion of CeA, triggered
a disruption of fear behavior in both stressed and non-stressed
animals. Moreover, and also in accordance with our previous
reports (Pêgo et al., 2008), the CUS protocol did not induce an
alteration in the fear-potentiated behavior. These facts demon-
strate that the contribution of the main output of the amygdala
(CeA) is quite distinct in these behaviors: while it is determi-
nant for the fear-potentiated startle in non-stressed conditions,
the effect in anxiety-like behavior is only present when this behav-
ior is being triggered by a complementary insult (in the present
case, stress). This is not surprising when considering that the
neuronal circuits involved in fear-potentiated startle critically
depend on the projection of the CeA to the caudal pontine retic-
ular nucleus (Davis et al., 2010), whereas for anxiety behavior,
and for the control of HPA activity, the output of the CeA to
the BNST represent only one of the possible modulators of its
activity.
Given the topographical organization of the projections of the
CeA, it is likely that an excitotoxic lesion in CeA will lead to a
reduction of GABA and peptidergic inputs, particularly CRF, into
the anterior BNST (Veinante et al., 1997; Day et al., 1999). Taking
into account that the increase in CRF following chronic stress has
a fundamental role in the activation of anterior BNST and con-
sequent activation of the HPA axis (Ventura-Silva et al., 2012),
this might be one plausible explanation for the attenuation of the
stress-induced anxiety behavior in CeA lesioned animals. Of rel-
evance, a lesion in the anterior BNST induces an attenuation of
the activity of the HPA axis in a basal situation although no alter-
ations in animals submitted to chronic variable stress (Choi et al.,
2008a) in opposition to the posterior BNST that contributes to
the inactivation of the HPA axis (Choi et al., 2008b). These obser-
vations show that the anterior BNST seems to be essential for
the regulation of the HPA axis in a basal situation and together
with our observations, CeA contributes to the manifestation of a
stress-related phenotype.
In further support of this hypothesis is the fact that a lesion in
CeA did not affect anxiety-behavior in baseline conditions, which
is in line with previous observations by other labs (Möller et al.,
1997; McHugh et al., 2004; Cai et al., 2012). Our results are consis-
tent with reports showing that the manipulation of CeA can affect
the expression of anxiety-like behavior. In particular, lentiviral
overexpression of CRF in the CeA results in the dysregulation of
the hypothalamic-pituitary-adrenal (HPA) axis and alterations in
the baseline response to acoustic stimuli (Keen-Rhinehart et al.,
2009).
In summary, we observed that, in control animals, a lesion in
CeA triggers an alteration in the fear-potentiated startle but not in
anxiety-like behavior. Nevertheless, when animals are submitted
to a chronic stress protocol the CeA lesion partially attenuates the
development of anxiety-like behavior. These findings contribute
to better understand the role of the CeA in the pathogenesis
of anxiety and fear behavior and in the sense to know how its
modulation might be of relevance for the control of emotional
disturbances involving such behaviors but also for the control of
HPA activity.
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